Kelly W. Yang

Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice

Scott A. Scarneo, Liesl S. Eibschutz, Phillip J. Bendele et al. · Arthritis Research & Therapy · 2019 · 49 citations · Full text

A highly selective inhibitor of interleukin-1 receptor–associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase

Scott A. Scarneo, Philip F. Hughes, Kelly W. Yang et al. · Journal of Biological Chemistry · 2019 · 26 citations · Full text

Development and Efficacy of an Orally Bioavailable Selective TAK1 Inhibitor for the Treatment of Inflammatory Arthritis

Scott A. Scarneo, Philip F. Hughes, Robert Freeze et al. · ACS Chemical Biology · 2022 · 23 citations · Full text

The approaching pilot for One Health governance index

Odel Y. Li, XiangCheng Wang, Kelly W. Yang et al. · Infectious Diseases of Poverty · 2023 · 21 citations · Full text

TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades

Scott A. Scarneo, Kelly W. Yang, Jose Roques et al. · Oncotarget · 2020 · 12 citations · Full text